Escherichia coli serotype 0157:H7 was incriminated as the agent responsible for two outbreaks of hemorrhagic colitis that occurred in the United States during 1982 (23, 26) . The E. coli 0157:H7 strains isolated during these outbreaks did not produce either heat-labile or heat-stable enterotoxin, nor were they enteroinvasive (26) . However, two isolates from patients and an isolate (strain 933) from ground beef, which was implicated as the vehicle in these outbreaks, produced high levels of cell-associated and cellfree cytotoxin active on Toxin from E. coli 933 was purified to apparent homogeneity and shown to have biologic activities similar to those of Shigella dysenteriae type 1 (17) . The cytotoxin produced in large amounts by E. coli K-12 lysogenized with phage 933J can be neutralized by antiserum against Shiga toxin (17) . The structural genes for this toxin were cloned from phage 933J DNA and shown by Southern hybridization to have homology with DNA from S. dysenteriae type 1 and Shigellaflexneri (13) . Recent studies in our laboratory demonstrated that the cytotoxin produced by E. coli K-12(933W) was not neutralized by anti-Shiga toxin, in contrast with our original report on 933W toxin (17) . Toxins. Bacteria were grown for 48 h in Chelex-treated syncase medium as previously described (16) . Culture supernatants were collected and bacterial lysates were prepared either by the French press method (16) or by sonication (14) .
Polyclonal rabbit antisera. Antibody to purified Shiga toxin was raised in rabbits according to published procedures (15) . Antibody to crude 933W toxin was raised in rabbits by a series of 13 intramuscular inoculations of extracellular culture fluid (0.2 ml) or cell extracts (0.05 to 0.2 ml) prepared from E. coli C600(933W) as previously described (24) Mouse lethality. The lethality of crude French press lysates from E. coli 933, E. coli C600, E. coli C600(933J), and E. coli C600(933W) was tested according to published procedures (18) . The 50% lethal dose (LD50) of each toxin was determined in the following way. Groups of five female (6 to 8 weeks old) CD-1 mice (Charles River Breeding Laboratories, Inc., Kingston, N.Y.) were inoculated intraperitoneally with various doses of bacterial lysates diluted in phosphatebuffered saline that contained 0.1% (wt/vol) gelatin. The mice were observed daily over a 10-day period for hind-leg paralysis and death. The LD50s were calculated by the method of Reed and Muench (21) .
Enterotoxicity assay. French press lysates of E. coli 933, E. coli C600, E. coli C600(933J), and E. coli C600(933W) were tested for enterotoxic activity in ligated rabbit ileal segments as previously described (3) . One milliliter of bacterial lysate (undiluted) was inoculated per segment. Each sample was tested in eight ligated segments of different rabbits. A sample was considered to contain enterotoxin if the average of the volume-to-length ratios of the eight inoculated segments was -1.0 ml/cm.
Restriction endonuclease digestion and hybridization analysis of 933W phage DNA. DNA from phages 933W and 933J was prepared as previously described (17) and digested with BamHI, Salil, or EcoRI (International Biotechnologies, Inc., New Haven, Conn.) according to the recommendations of the manufacturer. DNA fragments were separated electrophoretically on 0.7% (wt/vol) agarose gels, blotted onto nitrocellulose paper, and probed as previously described (2, 12) . Probe pJN25 contains a 3.0-kilobase insert from phage 933J that encodes the 933J cytotoxin (13) . Approximately half of the 3.0-kilobase insert from phage 933J is estimated to code for toxin, while the other half represents phage sequences. The pJN25 probe was radiolabeled by nick translation using 32P-labeled dCTP and a commercially available kit (Bethesda Research Laboratories, Inc., Gaithersburg, Md.). The hybridization with the 32P-labeled pJN25 probe was performed in 5x SSPE (0.9 M NaCl, 50 mM NaH2PO4* 2H2O, 5 mM disodium EDTA; pH 7.4) at 50°C or 65°C overnight. Washing was done at room temperature if the hybridization was performed at 50°C or at 50°C if the hybridization was performed at 65°C. As a control, the digested 933W phage DNA was also probed with 32P-labeled pBR328 (the vector plasmid contained in pJN25) under conditions allowing approximately 36% mismatch. The blots were exposed to Kodak X-AR film (Eastman Kodak Co., Rochester, N.Y.) in the presence of intensifying screens.
RESULTS
Biologic activities of the 933J and 933W toxins. As shown in coli 933, E. coli C600(933J), and E. coli C600(933W) were also selectively cytotoxic for HeLa cells (Table 2 ) and Vero cells (not shown), but the culture supernatant of E. coli C600 contained no demonstrable cytotoxic activity. This is the same pattern of cytotoxicity that has been reported for Shiga toxin from S. dysenteriae type 1 (9, 19) .
The amounts of cytotoxin present in extracts of E. coli 933, E. coli C600, E. coli C600(933J), and E. coli C600(933W) differed greatly (Tables 1 and 2 ). Typically, sonic lysates of E. coli 933 were 10,000-to 100,000-fold more toxic than lysates from E. coli C600. Lysates from E. coli C600(933J) were approximately 1,000-fold more toxic than lysates from E. coli C600(933W). In contrast, the toxicity of sonic lysates of E. coli C600 did not exceed 100 CD5W/ml and was much lower than the toxicity of lysates from C600(933J) or C600(933W). The cytotoxicity of extracts prepared by the French press method was typically greater than the cytotoxicity of sonic lysates by about 10-fold.
French press lysates of E. coli 933, E. coli C600(933J), and E. coli C600(933W) were capable of paralyzing and killing mice. The lysate of E. coli C600 did not cause these effects (Table 1 Table  2) . In these assays, a constant amount of antibody was mixed with various amounts of lysate or supernatant. Under these circumstances, cytotoxicity is detected if the amount of homologous cytotoxin exceeds the neutralizing capacity of the antitoxin, or heterologous (non-neutralizable) cytotoxin is present, or both. To distinguish among these alternatives, samples of lysates or supematants were also treated with mixtures of antisera capable of neutralizing the 933J and 933W toxins. The cytotoxic activities in the lysate and culture supernatant of E. coli C600(933J) were neutralized by monoclonal antibody against the B subunit of Shiga-like toxin (MAb 13C4) or by anti-Shiga toxin, but they were not neutralized by anti-933W toxin. In contrast, the cellassociated and cell-free cytotoxins from E. coli C600(933W) were neutralized by anti-933W toxin, but they were not 53, 1986 neutralized either by MAb 13C4 or by anti-Shiga toxin. This lack of cross-neutralization demonstrates that the phageencoded 933J and 933W toxins are antigenically distinct.
The cytotoxicity of extracts of E. coli C600 was usually neutralized by MAb 13C4 and by rabbit anti-Shiga toxin (data not shown), confirming previous reports (16, 25) , but the rabbit anti-933W toxin did not neutralize the E. coli C600 cytotoxin. Occasionally either no activity could be detected with E. coli C600 lysates or they exhibited low titers of nonspecific cytotoxicity that could not be neutralized either with anti-Shiga toxin or with anti-933W toxin.
The lysate of E. coli 933 contained a high level of cytotoxic activity (Table 2) which was neutralized by MAb 13C4 or anti-Shiga toxin, but which was not neutralized by rabbit anti-933W toxin. However, a mixture of rabbit anti-Shiga toxin and rabbit anti-933W toxin neutralized the toxicity of the E. coli 933 lysate to a greater extent than anti-Shiga toxin alone, suggesting that a second toxin was present at a lower level. In contrast, the mixture of antitoxins was no more effective against the toxin from C600(933J), or C600(933W) than was the single, active antitoxin in the mixture. These control experiments demonstrated that anti-Shiga toxin and anti-933W antitoxins did not act additively or synergistically to enhance the neutralization of 933J or 933W cytotoxin. Therefore, the results obtained with lysates of strain 933 demonstrated the presence of two distinct cytotoxins which were antigenically related to the toxins encoded by phages 933J and 933W.
Culture supernatants of E. coli 933 also contained 933J and 933W toxin, but their relative titers varied from one supernatant to another. This variability has led to inconsistent neutralization results for the extracellular cytotoxicity with anti-Shiga toxin. Our findings with this antiserum and culture supernatants from strain 933 have ranged from complete neutralization (O'Brien et al., Lancet i:702, 1983) to partial or no demonstrable neutralization. A second problem that has also led to inconsistent neutralization results is the loss of 933W activity in some cultures of 933 left at 4°C on agar plates for more than 3 months.
In the experiment presented in Tab-le 2, the relative titers of 933J and 933W toxin in the culture supernatant of strain 933 were the reverse of those seen in cell lysates. The anti-933W toxin neutralized cytotoxic activity in culture supernatants, but neither anti-Shiga toxin nor monoclonal antibody to Shiga-like toxin had this effect. That the 933J toxin was in fact present in culture supernatants was evident from the more dramatic reduction in cytotoxic activity when a mixture of anti-Shiga toxin and anti-933W toxin was used rather than anti-933W toxin alone.
Neutralization of the cytotoxic activity from clinical isolates of E. coli. Dis., in press) recently surveyed 418 E. coli strains for production of Shiga-like toxin and identified 49 elevated cytotoxin-producing isolates (moderate and high producers). The cell-associated cytotoxicity of 39 of these strains was neutralized by anti-Shiga toxin, but for 10 strains the cellassociated cytotoxicity could not be neutralized by antiShiga toxin. In the present study, the antiserum prepared for analysis of the 933W-encoded toxin was used (on the basis of the neutralization data in Table 2 ) to determine whether the cell-associated cytotoxicity of the 10 strains not neutralized by anti-Shiga toxin could be neutralized by anti-933W crude toxin. The isolates that produced toxin which was not neutralized by anti-Shiga toxin included four strains (0157:H7) from patients with hemorrhagic colitis, two strains (0113:H21) from patients with hemolytic uremic syndrome, one strain (0157:H7) from a patient with diarrhea, and three strains (04:NM, 08:H9, 0149:H8) from calves with diarrhea. The cytotoxic activity in lysates from all 10 isolates was neutralized by the rabbit antiserum against crude 933W toxin. In addition, the cell-associated cytotoxic activity of one E. coli 0157:H-strain (E32511) described by Scotland et al. (S. M. Scotland, H. R. Smith, and B. Rowe, Letter, Lancet i:885-886, 1985) was only neutralized by rabbit anti-933W toxin. The cytotoxic activity in culture supernatants of E32511 and of 27 strains reported by Marques et al. (Marques et al., in press) as not neutralized by anti-Shiga toxin, was found in this investigation to be neutralized by either anti-Shiga toxin plus anti-933W toxin or anti-933W toxin alone (the 10 strains described above). Therefore, some clinical isolates produce cytotoxin antigenically related to the 933W toxin, and this antigenic variant of Shiga-like toxin may play a role in the pathogenesis of diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome. The relative contributions of the 933J and 933W types of Shiga-like toxin to the virulence of E. coli strains that produce both toxins remains to be determined.
Homology of the 9331 and 933W toxin genes. To compare the relatedness of the toxin genes at the DNA level, Southern hybridization experiments were performed between restriction fragments of phage 933W DNA and the pJN25 DNA probe for the intact structural genes for Shiga-like toxin from phage 933J. Under the more stringent hybridization conditions tested, estimated to permit no more than 26% base-pair mismatch, pJN25 hybridized to at least one band from phage 933W DNA digested with EcoRI, SalI, or BamHI, either singly or in pairwise combinations (Fig. 1) . In control experiments, labeled DNA from the pBR328 vector did not hybridize to the restricted 933W phage DNA under less stringent conditions, estimated to permit up to 36% mismatch (data not shown). These results demonstrate that the cloned DNA insert is responsible for the hybridization of the pJN25 probe with the 933W DNA and provide evidence that the 933J and 933W toxins have homologous nucleotide sequences. Definitive proof for their homology, however, will require the use of probes that are known to be completely internal to the toxin structural genes.
DISCUSSION
The major conclusion from this study is that the Shiga-like toxin encoded by phage 933W is antigenically distinct from, but homologous with, the Shiga-like toxin encoded by phage 933J. Data from the cross-neutralization experiments with the polyclonal antisera and with MAb 13C4, which is specific for an epitope on the B subunit of Shiga-like toxin (25) , did not demonstrate any shared epitopes between the 933W and 933J toxins. Nevertheless, the 933J-and 933W-encoded toxins appear to be homologous both functionally and genetically. Their similar biologic activities, as well as their identical target cell specificities ( Table 1 ), suggest that both their receptor-binding function and their mode of action, which in the case of Shiga toxin is inhibition of protein synthesis (22) , may be similar. One difference in the biologic activities of the 933W and 933J toxins is the ratio of LD50 to CD50 per milligram of cell lysate protein. The genetic relatedness of the 933W and 933J toxins is suggested by the homology between the cloned 933J toxin genes and 933W phage DNA in the Southern hybridization studies.
Evidence supporting the existence of antigenically distinct cytotoxins from E. coli has been reported by several investigators (7, 10, 11, 24, 27 -886, 1985) . The name verotoxin has been used in reference to the Vero cell cytotoxin from E. coli that was originally described in 1977 by Konowalchuk et al. (11) . Thus, the term verotoxin was coined before the recognition that the Vero cell-and HeLa cell-active toxins produced by E. coli and S. dysenteriae 1 relationships between the members of the family of Shigalike toxins will ultimately be defined at the genetic level by the nucleotide sequences of their structural genes. Such information will also provide a definitive basis for establishing a nomenclature that accurately reflects the relationships between Shiga toxin and the Shiga-like toxins. We thank Samuel B. Formal and Hugh Collins of the Walter Reed Army Institute of Research for performing the enterotoxicity assays. We also thank Edda Twiddy, Uniformed Services University of the Health Sciences, for assisting with the Y-1 cytotoxicity assays. We gratefully acknowledge Sylvia Scotland, Sara Rothman, Helge Karch, Sherwood Gorbach, and Michael Doyle for communicating to us their observations that. anti-Shiga toxin did not completely neutralize the cytotoxic activity present in culture supernatants of E. coli 933.We also thank Helge Karch for sharing his unpublished data comparing the mouse lethality of E. coli strains C600(933W) and C600(933J).
1985). To avoid confusion, the nomenclature for the antigenic variants should be addressed. We propose that the name Shiga-like toxin I be applied to the 933J toxin and related toxins which are neutralized by antiserum against Shiga toxin from S. dysenteriae type 1 strain 60R. The name Shiga-like toxin II is suggested for the 933W toxin and toxins neutralized by antibodies to 933W toxin. Specific antisera raised against each purified prototype toxin should be used to identify which antigenic variant is produced. We have made antibodies against purified Shiga toxin and monoclonal antibodies against Shiga-like toxin I from E. coli, and we are now in the process of purifying the 933W toxin and raising polyclonal and monoclonal antibodies against it. Once purified 933W toxin is available, we will also be able to compare directly the specific activities of the 933J and 933W toxins in each of the available bioassays.
LITERATURE CITED
